Results 11 to 20 of about 7,285,650 (306)
B-cell involvement in chronic graft-versus-host disease
Haematologica, 2008 Chronic graft-versus-host disease is a serious complication in long-term survivors of allogeneic hematopoietic stem cell transplantation, with several organ systems affected.
Rick Kapur +2 more
doaj +2 more sources
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease [PDF]
Haematologica, 2010 Background Multipotent mesenchymal stromal cells suppress T-cell function in vitro, a property that has underpinned their use in treating clinical steroid-refractory graft-versus-host disease after allogeneic hematopoietic stem cell transplantation ...
Melinda E. Christensen +8 more
doaj +2 more sources
NOTCH and Graft-Versus-Host Disease [PDF]
Frontiers in Immunology, 2018 In allogeneic hematopoietic stem cell transplantation, which is the major curative therapy for hematological malignancies, T cells play a key role in the development of graft-versus-host disease (GvHD).
Mauro Di Ianni +15 more
doaj +5 more sources
Patient-reported outcomes and health status associated with chronic graft-versus-host disease [PDF]
Haematologica, 2018 Chronic graft-versus-host disease occurs in 20–50% of allogeneic hematopoietic cell transplant survivors. We surveyed patients about their quality of life, symptoms, health status, comorbid conditions and medications.
Stephanie J. Lee +8 more
doaj +2 more sources
Chronic graft-versus-host disease – the role of dermatological treatment [PDF]
Przegląd Dermatologiczny, 2017 Introduction . The number of allogeneic haematopoietic stem cell transplantations is increasing year by year. The most common long-term complication is chronic graft-versus-host disease, with skin involvement noted in over 90% of cases. Objective . To
Magdalena Żychowska +3 more
doaj +2 more sources
Ocular Graft versus Host Disease
Vision Pan-America, 2015 Allogeneic hematopoietic stem cell transplantation is considered the standard of care for hematological and lymphoid malignancies. One of the complications associated to this therapy is an immune-mediated reaction known as graft versus host disease with ...
Paulo E.C. Dantas
doaj +2 more sources
Novel regulatory therapies for prevention of Graft-versus-host disease [PDF]
BMC Medicine, 2012 Graft-versus-host disease is one of the major transplant-related complications in allogeneic hematopoietic stem cell transplantation. Continued efforts have been made to prevent the occurrence of severe graft-versus-host disease by eliminating or ...
Leventhal Joseph +4 more
doaj +3 more sources
Skin-Limited Graft-versus-Host Disease after Pancreatic Transplantation
Case Reports in Transplantation, 2017 Introduction. The phenomenon of graft-versus-host disease, a solid organ transplant recipient, is a rare development with a very poor prognosis. Case Presentation.
Muneeb Ilyas +5 more
doaj +2 more sources
PLoS ONE, 2021 Graft-versus-host disease is a major complication after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Immunosuppressive drugs, such as anti-thymocyte globulin, alemtuzumab, and post-transplant cyclophosphamide, have ...
Kiyomi Mashima +17 more
doaj +1 more source
Graft-versus-host disease [PDF]
BMJ Case Reports, 2010 This article presents the case of a 26-year-old man who was diagnosed with pneumatosis cystoides intestinalis, a rare consequence of colonic graft-versus-host disease, after CT imaging revealed free air tracking within the bowel wall and abdomen. His presentation with hiccups, abdominal and neck distension, along with diarrhoea was also unusual, and ...
Joel A, Newman +4 more
openaire +2 more sources